About Thomas Cannon
Thomas Cannon is a director at NovAb.
Thomas Cannon first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Cannon in the role, so the role may have started earlier or lasted longer.
NovAb, Inc.
Director
2024 – 2026 · Tucker, GA
Develops antibodies for potential diagnostic and therapeutic uses.
Key Colleagues at Startups
The people Thomas Cannon works with at each company, as listed on that company's latest Form D.
NovAb, Inc. · Form D, Apr 16, 2026
GD
Gregory Dane
Director
LC
Lovick Cannon
President and Chairman, Board of Directors